|
|
neural tube formation
|
GO:0001841 |
108 |
0.814
|
|
|
|
neural crest cell migration involved in autonomic nervous system development
|
GO:1901166 |
5 |
0.793
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.743
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.670
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.660
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.654
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.591
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.571
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.566
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.549
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.543
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.527
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.496
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.495
|
|
|
|
hindbrain tangential cell migration
|
GO:0021934 |
2 |
0.473
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.465
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.453
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.437
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.420
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.410
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.387
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.355
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.354
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.354
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.344
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.343
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.342
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.342
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.338
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.318
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.304
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.303
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.285
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.284
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.282
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.279
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.279
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.277
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.271
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.271
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.261
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.252
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.248
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.247
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.247
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.245
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.241
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.240
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.239
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.235
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.230
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.230
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.229
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.222
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.221
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.220
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.217
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.216
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.216
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.215
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.212
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.206
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.204
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.203
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.203
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.203
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.202
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.200
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.197
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.194
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.191
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.189
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.187
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.186
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.184
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.184
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.183
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.182
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.180
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.179
|
|
|
|
neural crest formation
|
GO:0014029 |
2 |
0.177
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.173
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.173
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.170
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
7 |
0.170
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.168
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.166
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.166
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.163
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.157
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.156
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.154
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.151
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.148
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.147
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.147
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.146
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.145
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.145
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.144
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.142
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.140
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.140
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.139
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.137
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.137
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.136
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.135
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.134
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.130
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.129
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.129
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.129
|
|
|
|
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
GO:0021938 |
4 |
0.129
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.127
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.127
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.126
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.126
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.125
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.125
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.125
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.124
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.124
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.124
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.124
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.123
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.122
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.122
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in forebrain neuron fate commitment
|
GO:0021882 |
3 |
0.121
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.120
|
|
|
|
cellular response to cholesterol
|
GO:0071397 |
2 |
0.120
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.120
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.119
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.119
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.119
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.118
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.118
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.118
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.116
|
|
|
|
noradrenergic neuron development
|
GO:0003358 |
3 |
0.114
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.113
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.112
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.111
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.110
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.109
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.109
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.109
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.108
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.108
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.107
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.107
|
|
|
|
regulation of neuron maturation
|
GO:0014041 |
5 |
0.106
|
|
|
|
cerebral cortex gabaergic interneuron fate commitment
|
GO:0021893 |
2 |
0.105
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.105
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.104
|
|
|
|
apoptotic process involved in outflow tract morphogenesis
|
GO:0003275 |
2 |
0.104
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.103
|
|
|
|
locus ceruleus development
|
GO:0021703 |
1 |
0.103
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.103
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.102
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.101
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.101
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.099
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.098
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.098
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.097
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.097
|
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.096
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.096
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.095
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.094
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.094
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.094
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.093
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.093
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.092
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.090
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.090
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.090
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.090
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.090
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.090
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.090
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.089
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.089
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.089
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.089
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.088
|
|
|
|
negative regulation of epidermis development
|
GO:0045683 |
9 |
0.088
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.088
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.087
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.086
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.086
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.085
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.084
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.084
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.084
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.083
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.083
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.083
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.081
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.080
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.080
|
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.080
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.079
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.079
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.078
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.078
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.078
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.078
|
|
|
|
positive regulation of tendon cell differentiation
|
GO:2001051 |
1 |
0.077
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.077
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.077
|
|
|
|
regulation of male germ cell proliferation
|
GO:2000254 |
3 |
0.076
|
|
|
|
positive regulation of skeletal muscle fiber differentiation
|
GO:1902811 |
2 |
0.075
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.075
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.075
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.075
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.074
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.073
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.073
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.073
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.072
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.072
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.072
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.072
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.072
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.071
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.071
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.071
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.070
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.070
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.070
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.069
|
|
|
|
positive regulation of non canonical wnt signaling pathway
|
GO:2000052 |
6 |
0.069
|
|
|
|
negative regulation of cell maturation
|
GO:1903430 |
9 |
0.069
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.069
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.069
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.069
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.068
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.068
|
|
|
|
negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation
|
GO:0060829 |
1 |
0.068
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.067
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.067
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.067
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.067
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.066
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.066
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.066
|
|
|
|
embryonic skeletal joint morphogenesis
|
GO:0060272 |
11 |
0.065
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.065
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.064
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.064
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.064
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.063
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.063
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.063
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.062
|
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.062
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.062
|
|
|
|
positive regulation of tongue muscle cell differentiation
|
GO:2001037 |
2 |
0.061
|
|
|
|
cardioblast differentiation
|
GO:0010002 |
13 |
0.061
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.061
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.061
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.061
|
|
|
|
neural crest cell fate commitment
|
GO:0014034 |
1 |
0.060
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.060
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.060
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.060
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.059
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.059
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.059
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.059
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.058
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.058
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.057
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.057
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.057
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.057
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.057
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.057
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.056
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.056
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
10 |
0.056
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.056
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.056
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.055
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.055
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.055
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.055
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.055
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.055
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.055
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.055
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.054
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.054
|
|
|
|
regulation of cell maturation
|
GO:1903429 |
13 |
0.054
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.053
|
|
|
|
cell proliferation involved in metanephros development
|
GO:0072203 |
9 |
0.053
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.053
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.053
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.053
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.053
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.053
|
|
|
|
somite specification
|
GO:0001757 |
4 |
0.052
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.052
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.052
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.052
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.052
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.052
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.052
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.051
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.051
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.051
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.051
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.051
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.051
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.050
|
|
|
|
commitment of multipotent stem cells to neuronal lineage in forebrain
|
GO:0021898 |
3 |
0.050
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.050
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.050
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.050
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.050
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.050
|
|
|
|
ventricular zone neuroblast division
|
GO:0021847 |
3 |
0.050
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.050
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.050
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.050
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.050
|
|
|
|
medulla oblongata development
|
GO:0021550 |
3 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.050
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.049
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.049
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.049
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.049
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.049
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.049
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.049
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.049
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.048
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.048
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.048
|
|
|
|
tangential migration from the subventricular zone to the olfactory bulb
|
GO:0022028 |
5 |
0.048
|
|
|
|
melanocyte migration
|
GO:0097324 |
2 |
0.048
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.048
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.048
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.048
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.047
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.047
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.047
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.047
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.047
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.047
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.047
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.047
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.046
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.046
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.046
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.046
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.046
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.046
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.046
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.046
|
|
|
|
neural plate development
|
GO:0001840 |
12 |
0.045
|
|
|
|
cartilage morphogenesis
|
GO:0060536 |
11 |
0.045
|
|
|
|
regulation of cardiac chamber morphogenesis
|
GO:1901219 |
2 |
0.044
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.044
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.044
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.044
|
|
|
|
telencephalon regionalization
|
GO:0021978 |
14 |
0.044
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.044
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.043
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.043
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.043
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.043
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.043
|
|
|
|
glomerulus morphogenesis
|
GO:0072102 |
10 |
0.043
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.043
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.043
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.043
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.043
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.042
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.042
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.042
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.042
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.042
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.042
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.042
|
|
|
|
dichotomous subdivision of terminal units involved in ureteric bud branching
|
GO:0060678 |
1 |
0.042
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.042
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.042
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.042
|
|
|
|
renal system vasculature development
|
GO:0061437 |
15 |
0.042
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.041
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.041
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.041
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.041
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.041
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.041
|
|
|
|
axial mesodermal cell fate specification
|
GO:0048327 |
1 |
0.040
|
|
|
|
negative regulation of heart looping
|
GO:1901208 |
1 |
0.040
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.040
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.040
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.040
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.040
|
|
|
|
smoothened signaling pathway involved in ventral spinal cord patterning
|
GO:0021910 |
7 |
0.040
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.040
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.039
|
|
|
|
negative regulation of glial cell differentiation
|
GO:0045686 |
21 |
0.039
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.039
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.039
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.039
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.039
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.039
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.039
|
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.039
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.039
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.039
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.039
|
|
|
|
atrioventricular bundle cell differentiation
|
GO:0003167 |
1 |
0.039
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.039
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.039
|
|
|
|
smoothened signaling pathway involved in dorsal ventral neural tube patterning
|
GO:0060831 |
12 |
0.039
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.038
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.038
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.038
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.038
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.038
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.038
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.038
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.038
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.038
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.038
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.038
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.037
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.037
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.037
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
tongue muscle cell differentiation
|
GO:0035981 |
2 |
0.037
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.037
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.037
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.037
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.037
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.036
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.036
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.036
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.036
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.036
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.036
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.036
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.036
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.036
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.035
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.035
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.035
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.035
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.035
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.035
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.035
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
22 |
0.035
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.035
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.035
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.035
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.035
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.035
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.035
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.034
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.034
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.034
|
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.034
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.034
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.034
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.034
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.034
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.034
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.034
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.033
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.033
|
|
